DE602007012071D1 - Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen - Google Patents
Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungenInfo
- Publication number
- DE602007012071D1 DE602007012071D1 DE602007012071T DE602007012071T DE602007012071D1 DE 602007012071 D1 DE602007012071 D1 DE 602007012071D1 DE 602007012071 T DE602007012071 T DE 602007012071T DE 602007012071 T DE602007012071 T DE 602007012071T DE 602007012071 D1 DE602007012071 D1 DE 602007012071D1
- Authority
- DE
- Germany
- Prior art keywords
- affordable
- dopamine
- disorders
- receptor
- modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06007923 | 2006-04-14 | ||
| US79367106P | 2006-04-20 | 2006-04-20 | |
| PCT/EP2007/053633 WO2007118859A1 (en) | 2006-04-14 | 2007-04-13 | Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602007012071D1 true DE602007012071D1 (de) | 2011-03-03 |
Family
ID=40631425
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602007012071T Active DE602007012071D1 (de) | 2006-04-14 | 2007-04-13 | Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen |
Country Status (6)
| Country | Link |
|---|---|
| CN (1) | CN101421243B (zh) |
| AT (1) | ATE496031T1 (zh) |
| DE (1) | DE602007012071D1 (zh) |
| ES (1) | ES2360254T3 (zh) |
| PE (1) | PE20080057A1 (zh) |
| TW (1) | TWI400233B (zh) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW450954B (en) * | 1998-05-14 | 2001-08-21 | Pharmacia & Amp Upjohn Company | Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| AU2003218660A1 (en) * | 2002-02-13 | 2003-09-04 | Glaxo Group Limited | Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor liga ds |
| GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
-
2007
- 2007-04-13 DE DE602007012071T patent/DE602007012071D1/de active Active
- 2007-04-13 ES ES07728098T patent/ES2360254T3/es active Active
- 2007-04-13 PE PE2007000456A patent/PE20080057A1/es not_active Application Discontinuation
- 2007-04-13 AT AT07728098T patent/ATE496031T1/de not_active IP Right Cessation
- 2007-04-13 TW TW96113061A patent/TWI400233B/zh not_active IP Right Cessation
- 2007-04-13 CN CN2007800134447A patent/CN101421243B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101421243A (zh) | 2009-04-29 |
| TW200808727A (en) | 2008-02-16 |
| CN101421243B (zh) | 2012-05-30 |
| ATE496031T1 (de) | 2011-02-15 |
| ES2360254T3 (es) | 2011-06-02 |
| PE20080057A1 (es) | 2008-03-10 |
| TWI400233B (zh) | 2013-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0918527A2 (pt) | compostos para o tratamento de disturbios do cns | |
| GB0703909D0 (en) | Treatment of anxiety disorders | |
| BR112012013260A2 (pt) | dispositivo usado para o tratamento de rinite através de iluminação bioestimulativa | |
| IL205671A0 (en) | Novel cyclic hydrocarbon compounds for the treatment of diseases | |
| HK1152939A1 (zh) | 用於治療代謝障礙的甲酰胺化合物 | |
| FR2929125B1 (fr) | Appareil de securisation des secours effectues par helitreuillage | |
| SI2120963T1 (sl) | Substituirane spojine tetraciklina za zdravljenje vnetnih kožnih motenj | |
| DE602007006019D1 (de) | Für die behandlung von durch den gpr38-rezeptor vermittelten krankheiten geeignete piperazinylderivate | |
| FR2934857B1 (fr) | Nouveau procede de synthese de l'agomelatine | |
| IL194833A0 (en) | Polymorph forms of (2s)-(4e)-n-methyl-5-(3-isopropoxypyridin) yl]-4 penten-2-amine for the treatment of central nervous system disorders | |
| BRPI1009783A2 (pt) | compostos para o tratamento de distúrbios metabólicos. | |
| FR2934859B1 (fr) | Nouveau procede de synthese de l'agomelatine | |
| FR2933987B1 (fr) | Procede d'hydrogenation du benzene | |
| BRPI1013777A2 (pt) | compostos agonistas do receptor 5-ht4 para tratamento de distúrbios cognitivos. | |
| IL210489A0 (en) | Use of hdac inhibitors for the treatment of hodgkin's disease | |
| ATE524456T1 (de) | Zur behandlung von erkrankungen, die auf eine modulation des serotonin-5-ht6-rezeptors ansprechen, geeignete chinolinverbindung | |
| MA31830B1 (fr) | Nouveau procede de synthese de l'agomelatine | |
| HK1146628A1 (en) | 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor | |
| IL201899A0 (en) | Spiro compounds for treatment of inflammatory disorders | |
| IL226799A0 (en) | Proline analogs as ligands for cannabinoid receptors for pain relief | |
| DE602007012071D1 (de) | Für die behandlung von auf die modulierung des dopamin-d3-rezeptors ansprechende erkrankungen geeignete aryloxyethylaminverbindungen | |
| ATE535517T1 (de) | Benzolsulfonanilidverbindungen, die sich für die behandlung von erkrankungen eignen, die auf die modulation des serotonin-5-ht6-rezeptors ansprechen | |
| IL210558A0 (en) | Treatment of anxiety disorders | |
| ATE494891T1 (de) | Carbonylamino-derivate zur behandlung von entzündlicher darmerkrankung | |
| HK1129112A1 (en) | 2 -alkyl- indazole compounds for the treatment of certain cns-related disorders |